Skip to main content

Gerst Diane G.'s Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Jul 5, 2022

Accession no.
0001104659-22-077306
Filed
Jul 5, 2022
Trade date
Jun 30, 2022
Filing delay
5 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $180.1K. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Gerst Diane G.CIK 0001611283Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 30, 2022Common StockMOption exerciseAcquired+3,333$20.03+$66,759.9916,175Direct
Jun 30, 2022Common StockMOption exerciseAcquired+1,813$20.08+$36,405.0417,988Direct
Jun 30, 2022Common StockSSaleDisposed−5,146$35.00−$180,11012,842Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 30, 2022Common StockMOption exerciseDisposed−3,333$0.00$03,626Direct
Jun 30, 2022Common StockMOption exerciseDisposed−1,813$0.00$06,190Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)